Heart-Shield drugs tested for breast cancer patients
NCT ID NCT06844669
Summary
This study is testing if two common heart medications can prevent heart damage in people receiving a specific type of breast cancer treatment. It involves a small group of patients with HER2-positive breast cancer who are starting or recently started their cancer therapy. The goal is to see if taking these heart drugs alongside cancer treatment is safe, feasible, and might protect the heart, allowing patients to complete their cancer therapy without interruption.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.